Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R.

J Neurochem. 2011 May;117(3):528-37. doi: 10.1111/j.1471-4159.2011.07224.x. Epub 2011 Mar 21.

2.

pNfH is a promising biomarker for ALS.

Ganesalingam J, An J, Bowser R, Andersen PM, Shaw CE.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Mar;14(2):146-9. doi: 10.3109/21678421.2012.729596. Epub 2012 Oct 22.

PMID:
23134506
3.

Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.

Poesen K, De Schaepdryver M, Stubendorff B, Gille B, Muckova P, Wendler S, Prell T, Ringer TM, Rhode H, Stevens O, Claeys KG, Couwelier G, D'Hondt A, Lamaire N, Tilkin P, Van Reijen D, Gourmaud S, Fedtke N, Heiling B, Rumpel M, Rödiger A, Gunkel A, Witte OW, Paquet C, Vandenberghe R, Grosskreutz J, Van Damme P.

Neurology. 2017 Jun 13;88(24):2302-2309. doi: 10.1212/WNL.0000000000004029. Epub 2017 May 12.

PMID:
28500227
4.

Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.

Li S, Ren Y, Zhu W, Yang F, Zhang X, Huang X.

J Neurol Sci. 2016 Aug 15;367:269-74. doi: 10.1016/j.jns.2016.05.062. Epub 2016 Jun 1.

PMID:
27423602
5.

Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis.

McCombe PA, Pfluger C, Singh P, Lim CY, Airey C, Henderson RD.

J Neurol Sci. 2015;353(1-2):122-9. doi: 10.1016/j.jns.2015.04.032. Epub 2015 Apr 29.

6.

Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.

Chen X, Chen Y, Wei Q, Ou R, Cao B, Zhao B, Shang HF.

BMC Neurol. 2016 Sep 15;16:173. doi: 10.1186/s12883-016-0689-x.

7.

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.

Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, Johnston A, Overstreet K, Kelly C, Polak M, Shaw G.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):467-72. doi: 10.1136/jnnp-2012-303768. Epub 2012 Oct 31.

PMID:
23117489
8.

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.

Oeckl P Phd, Jardel C PharmD PhD, Salachas F Md, Lamari F Md, Andersen PM Md PhD, Bowser R PhD, de Carvalho M PhD, Costa J PhD, van Damme P Md PhD, Gray E PhD, Grosskreutz J Md, Hernández-Barral M Md, Herukka SK PhD Md, Huss A MSc, Jeromin A PhD, Kirby J PhD, Kuzma-Kozakiewicz M Md PhD, Amador Mdel M Md, Mora JS Md, Morelli C Md, Muckova P PhD, Petri S Md, Poesen K PharmD PhD, Rhode H Md, Rikardsson AK, Robberecht W Md PhD, Rodríguez Mahillo AI PhD, Shaw P Md, Silani V Md, Steinacker P PhD, Turner MR PhD, Tüzün E Md PhD, Yetimler B MSc, Ludolph AC Md, Otto M Md.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):404-13. doi: 10.3109/21678421.2016.1167913. Epub 2016 Apr 11.

PMID:
27415180
9.

Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.

Gendron TF; C9ORF72 Neurofilament Study Group, Daughrity LM, Heckman MG, Diehl NN, Wuu J, Miller TM, Pastor P, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Benatar M, Silani V, Glass JD, Floeter MK, Jeromin A, Boylan KB, Petrucelli L.

Ann Neurol. 2017 Jul;82(1):139-146. doi: 10.1002/ana.24980.

10.

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A.

Neurology. 2015 Jun 2;84(22):2247-57. doi: 10.1212/WNL.0000000000001642. Epub 2015 May 1. Erratum in: Neurology. 2015 Sep 8;85(10):921.

11.

Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.

Wang XK, Zhang HL, Meng FH, Chang M, Wang YZ, Jin T, Mix E, Zhu J.

Neurol Sci. 2013 May;34(5):655-61. doi: 10.1007/s10072-012-1092-z. Epub 2012 Apr 22.

PMID:
22526766
12.

Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings.

Ohya J, Chikuda H, Kato S, Hayakawa K, Oka H, Takeshita K, Tanaka S, Ogata T.

Spine J. 2015 Jul 1;15(7):1587-92. doi: 10.1016/j.spinee.2015.03.013. Epub 2015 Mar 20.

PMID:
25797810
13.

Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.

Gonçalves M, Tillack L, de Carvalho M, Pinto S, Conradt HS, Costa J.

Clin Chim Acta. 2015 Jan 1;438:342-9. doi: 10.1016/j.cca.2014.09.011. Epub 2014 Sep 28.

PMID:
25261856
14.

Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.

Weydt P, Oeckl P, Huss A, Müller K, Volk AE, Kuhle J, Knehr A, Andersen PM, Prudlo J, Steinacker P, Weishaupt JH, Ludolph AC, Otto M.

Ann Neurol. 2016 Jan;79(1):152-8. doi: 10.1002/ana.24552. Epub 2015 Dec 17.

PMID:
26528863
15.

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients.

Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM, von Arnim CA, Böhm S, Kassubek J, Kubisch C, Lulé D, Müller HP, Muche R, Pinkhardt E, Oeckl P, Rosenbohm A, Anderl-Straub S, Volk AE, Weydt P, Ludolph AC, Otto M.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):12-20. doi: 10.1136/jnnp-2015-311387. Epub 2015 Aug 21.

PMID:
26296871
16.

Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.

Wilke C, Deuschle C, Rattay TW, Maetzler W, Synofzik M.

Neurobiol Aging. 2015 Feb;36(2):1072-4. doi: 10.1016/j.neurobiolaging.2014.10.019. Epub 2014 Oct 18.

PMID:
25453560
17.

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.

Lehnert S, Costa J, de Carvalho M, Kirby J, Kuzma-Kozakiewicz M, Morelli C, Robberecht W, Shaw P, Silani V, Steinacker P, Tumani H, Van Damme P, Ludolph A, Otto M.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):344-50. doi: 10.3109/21678421.2014.884592. Epub 2014 Feb 28.

PMID:
24575871
18.

Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.

Xu Z, Henderson RD, David M, McCombe PA.

PLoS One. 2016 Oct 12;11(10):e0164625. doi: 10.1371/journal.pone.0164625. eCollection 2016. Review.

19.

Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B, Van Damme P, Poesen K.

J Neurol Neurosurg Psychiatry. 2017 Oct 20. pii: jnnp-2017-316605. doi: 10.1136/jnnp-2017-316605. [Epub ahead of print]

PMID:
29054919
20.

CSF markers in amyotrophic lateral sclerosis.

Tarasiuk J, Kułakowska A, Drozdowski W, Kornhuber J, Lewczuk P.

J Neural Transm (Vienna). 2012 Jul;119(7):747-57. doi: 10.1007/s00702-012-0806-y. Epub 2012 May 4. Review.

PMID:
22555610

Supplemental Content

Support Center